|
Feb 23
|
2 Recent Stock Splits You've Never Heard of That Certain Wall Street Analysts Think Could Soar 39% and 62%
|
|
Dec 30
|
Why Is Qiagen N.V. (QGEN) Among the Top CRISPR Stocks to Invest In?
|
|
Dec 30
|
New Product Offerings Support QIAGEN's Shares Amid Currency Woes
|
|
Dec 30
|
Here's Why Qiagen (QGEN) is a Strong Momentum Stock
|
|
Oct 18
|
Qiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
|
|
Oct 16
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
|
Oct 11
|
QIAGEN's TB Testing Business Gets New Exposure at Global Summit
|
|
Oct 11
|
OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies
|
|
Oct 10
|
QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications
|
|
Oct 10
|
QIAGEN N.V. to release results for Q3 2024 and hold webcast
|
|
Aug 1
|
Compared to Estimates, Qiagen (QGEN) Q2 Earnings: A Look at Key Metrics
|
|
Jul 31
|
Qiagen (QGEN) Tops Q2 Earnings and Revenue Estimates
|
|
Jul 31
|
Qiagen: Q2 Earnings Snapshot
|
|
Jul 31
|
QIAGEN delivers solid performance and exceeds outlook for Q2 2024
|
|
Jul 25
|
Ultragenyx (RARE) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
|
|
Jun 27
|
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children
|
|
May 16
|
Here's Why Investors Should Retain QIAGEN (QGEN) Stock Now
|
|
Apr 9
|
QIAGEN N.V. to release results for Q1 2024 and hold webcast
|
|
Apr 4
|
QIAGEN (QGEN) Boosts Cancer Research Suite With New Launches
|
|
Apr 3
|
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
|